Ryan Specialty Ownership

RYAN Stock  USD 73.38  0.82  1.11%   
Ryan Specialty owns a total of 125.73 Million outstanding shares. The majority of Ryan Specialty Group outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Ryan Specialty Group to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Ryan Specialty. Please pay attention to any change in the institutional holdings of Ryan Specialty Group as this could imply that something significant has changed or is about to change at the company. Also note that almost one million three hundred thirty-two thousand six hundred ninety-six invesors are currently shorting Ryan Specialty expressing very little confidence in its future performance.
 
Shares in Circulation  
First Issued
2020-03-31
Previous Quarter
272.7 M
Current Value
291.3 M
Avarage Shares Outstanding
175.8 M
Quarterly Volatility
80.4 M
 
Covid
Some institutional investors establish a significant position in stocks such as Ryan Specialty in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Ryan Specialty, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ryan Specialty Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Ryan Stock Ownership Analysis

About 14.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 2.28. Ryan Specialty Group last dividend was issued on the 4th of March 2025. Ryan Specialty Group Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. The company was founded in 2010 and is headquartered in Chicago, Illinois. Ryan Specialty operates under InsuranceSpecialty classification in the United States and is traded on New York Stock Exchange. It employs 3690 people. To find out more about Ryan Specialty Group contact Patrick Ryan at 312 784 6001 or learn more at https://www.ryanspecialty.com.
Besides selling stocks to institutional investors, Ryan Specialty also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Ryan Specialty's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Ryan Specialty's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Ryan Specialty Quarterly Liabilities And Stockholders Equity

9.65 Billion

Ryan Specialty Insider Trades History

About 14.0% of Ryan Specialty Group are currently held by insiders. Unlike Ryan Specialty's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Ryan Specialty's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Ryan Specialty's insider trades
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Ryan Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Ryan Specialty is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ryan Specialty Group backward and forwards among themselves. Ryan Specialty's institutional investor refers to the entity that pools money to purchase Ryan Specialty's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Principal Financial Group Inc2024-12-31
1.8 M
Geode Capital Management, Llc2024-12-31
1.8 M
Barclays Plc2024-12-31
1.7 M
Stephens Inv Mgmt Group Llc2024-12-31
1.6 M
Polar Capital Holdings Plc2024-12-31
1.5 M
Eagle Asset Management, Inc.2024-09-30
1.4 M
Morgan Stanley - Brokerage Accounts2024-12-31
1.3 M
Alliancebernstein L.p.2024-12-31
1.3 M
Sumitomo Mitsui Trust Group Inc2024-12-31
1.2 M
Vanguard Group Inc2024-12-31
9.9 M
Blackrock Inc2024-12-31
9.8 M
Note, although Ryan Specialty's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ryan Specialty Group Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ryan Specialty insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ryan Specialty's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ryan Specialty insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Patrick Ryan over a month ago
Acquisition by Patrick Ryan of tradable shares of Ryan Specialty at 69.5 subject to Rule 16b-3
 
Nicholas Cortezi over two months ago
Disposition of 8549 shares by Nicholas Cortezi of Ryan Specialty at 66.3285 subject to Rule 16b-3
 
Nicholas Cortezi over two months ago
Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 65.0328 subject to Rule 16b-3
 
Nicholas Cortezi over two months ago
Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 65.0228 subject to Rule 16b-3
 
Nicholas Cortezi over two months ago
Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 65.1273 subject to Rule 16b-3
 
Nicholas Cortezi over two months ago
Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 65.8361 subject to Rule 16b-3
 
Nicholas Cortezi over two months ago
Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 67.0052 subject to Rule 16b-3
 
Nicholas Cortezi over two months ago
Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 66.2564 subject to Rule 16b-3
 
Nicholas Cortezi over three months ago
Disposition of 5068 shares by Nicholas Cortezi of Ryan Specialty at 65.1455 subject to Rule 16b-3
 
Nicholas Cortezi over three months ago
Disposition of tradable shares by Nicholas Cortezi of Ryan Specialty at 65.0 subject to Rule 16b-3
 
Mark Katz over three months ago
Disposition of 15000 shares by Mark Katz of Ryan Specialty at 67.3222 subject to Rule 16b-3
 
Patrick Ryan over three months ago
Acquisition by Patrick Ryan of 150 shares of Ryan Specialty at 69.24 subject to Rule 16b-3

Ryan Specialty Outstanding Bonds

Ryan Specialty issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ryan Specialty Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ryan bonds can be classified according to their maturity, which is the date when Ryan Specialty Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Ryan Specialty Corporate Filings

4th of April 2025
Other Reports
ViewVerify
F4
2nd of April 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
27th of March 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
10K
21st of February 2025
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify

Pair Trading with Ryan Specialty

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ryan Specialty position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ryan Specialty will appreciate offsetting losses from the drop in the long position's value.

Moving together with Ryan Stock

  0.78ACT Enact Holdings Normal TradingPairCorr
  0.84AXS AXIS Capital HoldingsPairCorr

Moving against Ryan Stock

  0.68BX Blackstone Group Earnings Call TomorrowPairCorr
  0.67AMBC Ambac Financial GroupPairCorr
  0.57JRVR James River GroupPairCorr
  0.57AX Axos FinancialPairCorr
  0.51MBI MBIA IncPairCorr
The ability to find closely correlated positions to Ryan Specialty could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ryan Specialty when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ryan Specialty - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ryan Specialty Group to buy it.
The correlation of Ryan Specialty is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ryan Specialty moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ryan Specialty Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ryan Specialty can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Ryan Specialty Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ryan Specialty's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ryan Specialty Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ryan Specialty Group Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ryan Specialty Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ryan Specialty. If investors know Ryan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ryan Specialty listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.39
Dividend Share
0.44
Earnings Share
0.71
Revenue Per Share
20.332
Quarterly Revenue Growth
0.252
The market value of Ryan Specialty Group is measured differently than its book value, which is the value of Ryan that is recorded on the company's balance sheet. Investors also form their own opinion of Ryan Specialty's value that differs from its market value or its book value, called intrinsic value, which is Ryan Specialty's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ryan Specialty's market value can be influenced by many factors that don't directly affect Ryan Specialty's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ryan Specialty's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ryan Specialty is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ryan Specialty's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.